Neubase Therapeutics Inc (NBSE) stock is lower by -70.56% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives NBSE stock a score of 7 out of a possible 100.
That rank is influenced by a long-term technical score of 7. NBSE's rank also includes a short-term technical score of 15. NBSE has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on NBSE!